Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer
Age
18–64
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
First Cohort: Healthy Male and female adults 60 to 64 years of age at time of enrollment.
Second Cohort: Healthy Male and female adults 50 to 59 years of age at time of enrollment.
Third Cohort: Healthy Male and female adults 18 to 49 years of age at time of enrollment.
You may not be if
Previous immunization with any licensed or experimental pneumococcal vaccine.
Serious chronic disorders including metastatic malignancy, severe chronic obstructive pulmonary disease (COPD) requiring supplemental oxygen, end stage renal disease with or without dialysis, clinically unstable cardiac disease, or any other disorder which in the investigator's opinion precludes the subject from participating in the study.
Known or suspected impairment of immunological function.
